Pages that link to "Q35857683"
Jump to navigation
Jump to search
The following pages link to Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. (Q35857683):
Displaying 50 items.
- Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals (Q24635002) (← links)
- Evolution of proviral gp120 over the first year of HIV-1 subtype C infection (Q24653373) (← links)
- Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth (Q27676728) (← links)
- Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys (Q28751926) (← links)
- Appreciating HIV type 1 diversity: subtype differences in Env. (Q30375834) (← links)
- Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways (Q33504599) (← links)
- Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection (Q33504604) (← links)
- Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys (Q33558407) (← links)
- Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure. (Q33606936) (← links)
- Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody response (Q33664910) (← links)
- Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies (Q33719511) (← links)
- Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission (Q33749206) (← links)
- Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection (Q33809419) (← links)
- Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. (Q33967039) (← links)
- A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression (Q33980469) (← links)
- Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection (Q34034659) (← links)
- Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections (Q34042642) (← links)
- Molecular evolution of HIV-1 CRF01_AE Env in Thai patients (Q34071790) (← links)
- Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection (Q34203163) (← links)
- HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression (Q34350944) (← links)
- Specificity of the autologous neutralizing antibody response (Q34415389) (← links)
- Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. (Q34428738) (← links)
- Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization (Q34441935) (← links)
- A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop (Q34463861) (← links)
- The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter (Q34485260) (← links)
- A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein (Q34733504) (← links)
- HIV-1 envelope glycoprotein variable loops are indispensable for envelope structural integrity and virus entry (Q34924647) (← links)
- Genetic imprint of vaccination on simian/human immunodeficiency virus type 1 transmitted viral genomes in rhesus macaques (Q34962907) (← links)
- Antibody-Dependent Cell-Mediated Viral Inhibition Emerges after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys Coincident with gp140-Binding Antibodies and Is Effective against Neutralization-Resistant Viruses (Q34982646) (← links)
- Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom. (Q35012759) (← links)
- Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system (Q35060140) (← links)
- Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms (Q35161426) (← links)
- epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals (Q35192660) (← links)
- Feline immunodeficiency virus (FIV) neutralization: a review (Q35491705) (← links)
- Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual (Q35592911) (← links)
- Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. (Q35694015) (← links)
- Clade-specific differences between human immunodeficiency virus type 1 clades B and C: diversity and correlations in C3-V4 regions of gp120. (Q35857408) (← links)
- Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope. (Q35914362) (← links)
- Envelope variation as a primary determinant of lentiviral vaccine efficacy (Q36002639) (← links)
- Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses (Q36008380) (← links)
- Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth (Q36194234) (← links)
- Differentiating founder and chronic HIV envelope sequences. (Q36277153) (← links)
- The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection (Q36483346) (← links)
- Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses (Q36673173) (← links)
- Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. (Q36974754) (← links)
- Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design (Q36978861) (← links)
- Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma (Q37051645) (← links)
- Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination (Q37099729) (← links)
- Worldwide Genetic Features of HIV-1 Env α4β7 Binding Motif: The Local Dissemination Impact of the LDI Tripeptide (Q37138445) (← links)
- Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India (Q37179996) (← links)